|
|
Evidence-Based Statements (recommendation levels ) |
Grades / Levels of Evidence |
1.
The
use of GRBAS Scales for voice quality evaluation?
|
In the GRBAS Scales, four grades of scale are recommended because of their high reproduction rate and sufficient resolution |
Strong Recommendation |
A |
2. Using the VHI and V-RQOL as patient-reported outcome measures?
|
They are, strongly recommended as subjective evaluation tools for voice disorders as they are highly reliable and validated |
Strong Recommendation |
A |
3. Laryngoscopy use for the assessment of dysphonia?.
|
Laryngoscopy is an essential tool for visualization of the larynx to diagnose the cause of dysphonia |
Strong Recommendation |
A |
4. The use of laryngostroboscopy in dysphonia?
|
Laryngostroboscopy is useful for diagnosis of voice disorders. It is also useful for the diagnosis and monitoring. Laryngostroboscopy was useful for the diagnosis of patients with voice disorders in 27.2% of cases |
Recommendation |
C |
5. Using acoustic analysis of voice clinically
|
Acoustic analysis is useful in objective evaluation of voice disorders, especially for evaluating effectiveness of treatment. |
Recommendation |
C |
6. The use of aerodynamic assessment of voice disorders
|
measurement of voice strength, measurement of pitch, measurement of expiratory flow in phonation, measurement of MPT, measured individually or combined |
Recommendation |
C |
7. Antireflux medication |
Clinicians should notprescribe antireflux medications to treat isolated dysphonia based on symptoms alone attributed to suspected gastroesophageal reflux disease (GERD) or laryngopharyngeal reflux (LPR), without visualization of the larynx |
Recommendation against |
C
|
8. Corticosteroid therapy |
Clinicians should notroutinely prescribe corticosteroids for patients with dysphonia prior to visualization of the larynx |
Recommendation against |
C
|
9. Antimicrobial therapy |
Clinicians should not routinely prescribe antibiotics to treat dysphonia.
|
Strong recommendation against |
A
|
10. Advocating for voice therapy |
clinicians should advocate voice therapy for patients with dysphonia from a cause amenable to voice therapy |
Strong recommendation |
A |
11. Imaging |
clinicians should not obtain computed tomography (CT) or magnetic resonance imaging (MRI) among patients with a primary voice complaint prior to visualization of the larynx |
Recommendation against |
c |
12. Education/prevention. |
Clinicians should inform patients with dysphonia about control/preventive measures |
Recommendation |
C |
13. Outcomes |
Clinicians should document resolution, improvement, or worsened symptoms of dysphonia or change in QOL among patients with dysphonia after treatment or observation. |
Recommendation |
C |
1. Evaluate the different modalities of voice therapy
Develop prognostic indicators to identify the benefits of voice analysis and its impact on selection of voice therapy modalities